DiscoverWTR Small-Cap SpotlightRevolutionizing Stroke Prevention: InspireMD’s CGuard® Prime and the Future of Carotid Stenting
Revolutionizing Stroke Prevention: InspireMD’s CGuard® Prime and the Future of Carotid Stenting

Revolutionizing Stroke Prevention: InspireMD’s CGuard® Prime and the Future of Carotid Stenting

Update: 2025-09-29
Share

Description

Send us a text

In this episode of WTR Small-Cap Spotlight, host Tim Gerdeman and WTR’s Robert Sassoon speak with Marvin Slosman, CEO of InspireMD (NASDAQ: NSPR), to discuss how the company is transforming carotid artery disease treatment with its groundbreaking CGuard® Prime Carotid Stent System. The conversation covers FDA approval, clinical data, market adoption, competitive positioning, and InspireMD’s long-term growth strategy.

Comments 
In Channel
loading
00:00
00:00
1.0x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Revolutionizing Stroke Prevention: InspireMD’s CGuard® Prime and the Future of Carotid Stenting

Revolutionizing Stroke Prevention: InspireMD’s CGuard® Prime and the Future of Carotid Stenting